Literature DB >> 21523508

GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis.

Makoto Ooi1, Shin Nishiumi, Tomoo Yoshie, Yuuki Shiomi, Michitaka Kohashi, Ken Fukunaga, Shiro Nakamura, Takayuki Matsumoto, Naoya Hatano, Masakazu Shinohara, Yasuhiro Irino, Tadaomi Takenawa, Takeshi Azuma, Masaru Yoshida.   

Abstract

OBJECTIVE: The roles that amino acids play in immunity and inflammation are well defined, and the relationship between inflammatory bowel disease (IBD) and certain amino acids has recently attracted attention. In this study, the levels of amino acids and trichloroacetic acid (TCA) cycle-related molecules in the colonic tissues and sera of patients with ulcerative colitis (UC) were profiled by gas chromatography/mass spectrometry (GC/MS), with the aim of evaluating whether the clinical state induced by UC leads to variations in the amino acid profile.
MATERIALS AND METHODS: Colonic biopsy samples from 22 UC patients were used, as well as serum samples from UC patients (n = 13), Crohn's disease (CD) patients (n = 21), and healthy volunteers (n = 17).
RESULTS: In the GC/MS-based profiling of amino acids and TCA cycle-related molecules, lower levels of 16 amino acids and 5 TCA cycle-related molecules were observed in the colonic lesion tissues of the UC patients, and the serum profiles of amino acids and TCA cycle-related molecules of the UC patients were different from those of the CD patients and healthy volunteers.
CONCLUSIONS: Our study raises the possibility that GC/MS-based profiling of amino acids and TCA cycle-related molecules is a useful early diagnostic tool for UC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523508     DOI: 10.1007/s00011-011-0340-7

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

Review 1.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 2.  Nutritional therapy for Crohn's disease in Japan.

Authors:  Toshiyuki Matsui; Toshihiro Sakurai; Tsuneyoshi Yao
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

3.  Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial.

Authors:  T Johnson; S Macdonald; S M Hill; A Thomas; M S Murphy
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

4.  Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.

Authors:  Feng Wu; Themistocles Dassopoulos; Leslie Cope; Anirban Maitra; Steven R Brant; Mary L Harris; Theodore M Bayless; Giovanni Parmigiani; Shukti Chakravarti
Journal:  Inflamm Bowel Dis       Date:  2007-07       Impact factor: 5.325

5.  Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage.

Authors:  Eran Israeli; Eduard Berenshtein; Dov Wengrower; Larisa Aptekar; Ron Kohen; Gershom Zajicek; Eran Goldin
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

6.  Body energy status and the metabolic response to acute inflammation.

Authors:  T A Lennie; D O McCarthy; R E Keesey
Journal:  Am J Physiol       Date:  1995-11

7.  Glutamine attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat.

Authors:  H Arndt; F Kullmann; F Reuss; J Schölmerich; K D Palitzsch
Journal:  JPEN J Parenter Enteral Nutr       Date:  1999 Jan-Feb       Impact factor: 4.016

Review 8.  Review article: medical treatment of severe ulcerative colitis.

Authors:  F Rizzello; P Gionchetti; A Venturi; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  2003-06       Impact factor: 8.171

9.  Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake.

Authors:  P R Ling; B R Bistrian; B Mendez; N W Istfan
Journal:  Metabolism       Date:  1994-03       Impact factor: 8.694

10.  Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages.

Authors:  Ayatoshi Andou; Tadakazu Hisamatsu; Susumu Okamoto; Hiroshi Chinen; Nobuhiko Kamada; Taku Kobayashi; Masaki Hashimoto; Tomohisa Okutsu; Kazutaka Shimbo; Tomoko Takeda; Hideki Matsumoto; Atsushi Sato; Hiroshi Ohtsu; Manabu Suzuki; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

View more
  42 in total

Review 1.  Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry.

Authors:  Masaru Yoshida; Naoya Hatano; Shin Nishiumi; Yasuhiro Irino; Yoshihiro Izumi; Tadaomi Takenawa; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2011-11-02       Impact factor: 7.527

2.  Regulation of the metabolite profile by an APC gene mutation in colorectal cancer.

Authors:  Tomoo Yoshie; Shin Nishiumi; Yoshihiro Izumi; Aya Sakai; Jun Inoue; Takeshi Azuma; Masaru Yoshida
Journal:  Cancer Sci       Date:  2012-04-12       Impact factor: 6.716

Review 3.  Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

Authors:  Anet A Soubières; Andrew Poullis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 4.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

Review 5.  Inflammatory bowel disease as a model for translating the microbiome.

Authors:  Curtis Huttenhower; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Immunity       Date:  2014-06-19       Impact factor: 31.745

6.  Metabolomics for the early detection of cisplatin-induced nephrotoxicity.

Authors:  Takeshi Ezaki; Shin Nishiumi; Takeshi Azuma; Masaru Yoshida
Journal:  Toxicol Res (Camb)       Date:  2017-08-29       Impact factor: 3.524

7.  Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.

Authors:  Shin Nishiumi; Yoshihiro Izumi; Masaru Yoshida
Journal:  Dig Dis Sci       Date:  2018-03-21       Impact factor: 3.199

Review 8.  Metabolic phenotyping in clinical and surgical environments.

Authors:  Jeremy K Nicholson; Elaine Holmes; James M Kinross; Ara W Darzi; Zoltan Takats; John C Lindon
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

Review 9.  Metabolomics as a diagnostic tool in gastroenterology.

Authors:  Vicky De Preter; Kristin Verbeke
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

10.  Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients.

Authors:  David J Nusbaum; Fengzhu Sun; Jie Ren; Zifan Zhu; Natalie Ramsy; Nicholas Pervolarakis; Sachin Kunde; Whitney England; Bei Gao; Oliver Fiehn; Sonia Michail; Katrine Whiteson
Journal:  FEMS Microbiol Ecol       Date:  2018-09-01       Impact factor: 4.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.